GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stella Pharma Corp (TSE:4888) » Definitions » Quick Ratio

Stella Pharma (TSE:4888) Quick Ratio : 11.90 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Stella Pharma Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Stella Pharma's quick ratio for the quarter that ended in Dec. 2023 was 11.90.

Stella Pharma has a quick ratio of 11.90. It generally indicates good short-term financial strength.

The historical rank and industry rank for Stella Pharma's Quick Ratio or its related term are showing as below:

TSE:4888' s Quick Ratio Range Over the Past 10 Years
Min: 4.44   Med: 11.33   Max: 27.13
Current: 11.9

During the past 5 years, Stella Pharma's highest Quick Ratio was 27.13. The lowest was 4.44. And the median was 11.33.

TSE:4888's Quick Ratio is ranked better than
84.06% of 1543 companies
in the Biotechnology industry
Industry Median: 3.59 vs TSE:4888: 11.90

Stella Pharma Quick Ratio Historical Data

The historical data trend for Stella Pharma's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Pharma Quick Ratio Chart

Stella Pharma Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23
Quick Ratio
27.13 6.81 4.44 11.04 6.77

Stella Pharma Quarterly Data
Mar19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.91 6.77 11.52 11.55 11.90

Competitive Comparison of Stella Pharma's Quick Ratio

For the Biotechnology subindustry, Stella Pharma's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stella Pharma's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stella Pharma's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Stella Pharma's Quick Ratio falls into.



Stella Pharma Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Stella Pharma's Quick Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Quick Ratio (A: Mar. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(3792.734-940.594)/421.585
=6.77

Stella Pharma's Quick Ratio for the quarter that ended in Dec. 2023 is calculated as

Quick Ratio (Q: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(3728.543-1040.533)/225.971
=11.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stella Pharma  (TSE:4888) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Stella Pharma Quick Ratio Related Terms

Thank you for viewing the detailed overview of Stella Pharma's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Stella Pharma (TSE:4888) Business Description

Traded in Other Exchanges
N/A
Address
3-2-7 Korai-bashi, Chuo-ku, Osaka Prefecture, Osaka, JPN, 541-0043
Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.

Stella Pharma (TSE:4888) Headlines

No Headlines